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To develop a case definition for the Pneumonia Etiology Research for Child Health (PERCH) project, we
sought a widely acceptable classification that was linked to existing pneumonia research and focused on very
severe cases. We began with the World Health Organization’s classification of severe/very severe pneumonia
and refined it through literature reviews and a 2-stage process of expert consultation. PERCH will study
hospitalized children, aged 1–59 months, with pneumonia who present with cough or difficulty breathing and
have either severe pneumonia (lower chest wall indrawing) or very severe pneumonia (central cyanosis,
difficulty breastfeeding/drinking, vomiting everything, convulsions, lethargy, unconsciousness, or head
nodding). It will exclude patients with recent hospitalization and children with wheeze whose indrawing
resolves after bronchodilator therapy. The PERCH investigators agreed upon standard interpretations of the
symptoms and signs. These will be maintained by a clinical standardization monitor who conducts repeated
instruction at each site and by recurrent local training and testing.
Despite the fact that pneumonia is the most common
cause of serious illness and death in young children
worldwide, our ability, as clinicians, to infer an infectious
pathological process in the lung from specific features of
the history and examination is poor. Many common
conditions of childhood, including malaria, bacterial
sepsis, and severe anemia, produce a spectrum of clinical
symptoms and signs that overlaps significantly with
pneumonia, and differentiating between these conditions
is challenging [1–4]. In adults, the definition of pneu-
monia relies heavily on characteristic changes on the
chest radiograph. However, many children who have
suggestive clinical signs of pneumonia and who respond
to appropriate antibiotics do not have any abnormalities
on the chest radiograph taken at the onset of the illness;
furthermore, radiological facilities are not always avail-
able in developing countries. In short, there is no single
definition of pneumonia in childhood that is sensitive,
specific, and can be widely implemented.
This article describes the clinical features and clas-
sifications available to define pneumonia in children
and reports the rationale for the definition adopted
by the Pneumonia Etiology Research for Child Health
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(PERCH) study and the process by which that definition was
developed and is being standardized across the 7 PERCH sites.
CLINICAL CASE DEFINITION
At the outset, we identified 5 criteria that would guide the de-
velopment of a clinical case definition for PERCH: (1) It should
be acceptable to and understandable by the majority of health-
care personnel throughout the developing world; (2) it should
capture the essence of the global public health problem of
pneumonia, which leads to 1.6 million deaths worldwide each
year [5]; (3) it should focus on children with severe pneumonia,
to target a reduction in child mortality; (4) it should permit the
findings of PERCH to bridge to published studies on pneu-
monia prevention and management over the last 30 years [6],
and integrate with analyses of the global burden of pneumonia
planned by the Child Health Epidemiology Research Group
(CHERG) [7]; and (5) it should be reproducible within and
between observers and within and between study sites.
Hospitalized Pneumonia
A key decision that needed to be made at the outset was how
broadly to target pneumonia cases throughout the healthcare
system. There is a compelling reason to begin by studying children
in the community; the majority of pneumonia episodes are
nonsevere and are managed in the community by healthcare
workers (HCWs) at primary healthcare facilities. However, if
the illness worsens, the child may progress through the hierarchy
of the healthcare system from primary to secondary or tertiary
care. At the same time, the etiology of pneumonia may also
evolve, for example, from a viral upper respiratory tract infection
to a viral lower respiratory tract infection and develop into a se-
vere illness through superinfection of the lung by opportunistic
colonizing bacteria. Studying children at all grades of severity
would provide valuable insights into pneumonia pathogenesis.
However, the resources required to undertake a comprehen-
sive etiology study at primary healthcare facilities, rather than
referral hospitals, would be very considerable. The procedures
used to define etiology, such as sputum induction, percutaneous
lung aspiration, pleural aspiration, and gastric lavage, are not
practicable without the support of an inpatient facility. The
focus of the study is on severe and potentially fatal pneu-
monia, and the most efficient way to capture such patients is
via hospital admissions.
World Health Organization Clinical Case Definition of
Pneumonia
During the 1980s, pediatricians and public health physicians
recognized that it was necessary to define, in terms easily mem-
orable to primary HCWs, the clinical features that justified
antibiotic use in children with potential pneumonia. A series
of studies was undertaken in developing countries to examine
the sensitivity and specificity of clinical symptoms and signs
of pneumonia: these included a history of cough or breath-
lessness, inability to feed, raised respiratory rate, lower chest
wall indrawing, fever, and tachycardia [8–12] (Table 1). In
1990, the World Health Organization (WHO) reviewed the
available evidence and produced a guideline that has been the
foundation of pneumonia detection in developing countries
ever since (Supplementary Figure 1) [13, 14].
The WHO algorithm is applied to children who present
with cough or difficulty breathing (Supplementary Figure 1).
These were introduced as ‘‘signs’’ [13], suggesting that they
are observed by HCWs, although in practice they are elicited
more commonly as part of the clinical history from the
parent. Fever was considered as a screening sign, but it lacked
both sensitivity and specificity for pneumonia [13]. Once
captured by the entry definition, the rest of the algorithm is
based around 3 management decisions: (1) Children with
pneumonia are treated with antibiotics, (2) those with severe
pneumonia are referred to the hospital, and (3) those with
very severe pneumonia are treated with oxygen therapy.
Integrated Management of Childhood Illnesses
With time, this definition was incorporated into the In-
tegrated Management of Childhood Illnesses (IMCI) strategy
[15], which provides triage and management guidelines at
the primary healthcare level, and into the WHO guidelines
for the management of children in hospital [16, 17]. It is
therefore known and accepted throughout the developing
world. Because it was incorporated into IMCI, the definition
of very severe pneumonia was influenced by the ‘‘danger’’
signs of ‘‘very severe disease,’’ an important concept for
triage regardless of the underlying syndrome, and the features
‘‘lethargy, convulsions or impaired consciousness’’ were added,
as was ‘‘vomiting everything.’’ In addition, the original definition
of pneumonia did not acknowledge the variation of clinical
presentation with age, so head nodding, a mark of respiratory
distress in young infants, was included and ‘‘unable to drink’’ was
extended to include ‘‘unable to breastfeed.’’
The primary objective of the WHO clinical case definition
was to capture the majority of cases of pneumonia for rapid
treatment with antibiotics and supportive therapy to reduce
childhood mortality. The assumption was that most severe
pneumonia was bacterial in origin and that making antibiotics
available to such children would save lives. Subsequently,
a meta-analysis of 9 community-based trials using the WHO
clinical case definition of nonsevere pneumonia confirmed
that antibiotics reduced all-cause mortality by 24% among
children ,5 years [18]. This pragmatic perspective has led to
a set of definitions that emphasizes sensitivity over specificity
to achieve substantial public health gains.
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Table 1. Studies of Childhood Pneumonia Contributing to the Formulation of the World Health Organization Clinical Case Definition
Study Site Sample Size
Gold Standard
Pneumonia Definition
Clinical Signs/Symptoms
Investigated
Conclusions Regarding
Definition
Shann et al [8] Goroka, Papua
New Guinea
350 Crepitations on
auscultation
Age, RR, lower chest
wall indrawing, cyanosis,
wheeze, pulse rate,
palpable liver,
temperature .37.5C,
feeds poorly
RR .50/minute was the most
accurate way to differentiate
pneumonia from nonpneumonia
Cherian et al [9] Vellore, Tamil Nadu,
India
682 Crepitations, wheeze,
bronchial breathing,
or radiological
abnormalities
RR, parental report of
rapid breathing,
intercostal retraction
Refined the value of RR by
age stratification to .50 for
infants and .40 for children .12 months
Campbell et al [10] Banjul, The Gambia 222 (episodes of
illness in a cohort study)
Radiological signs
(lobar consolidation)
Vomiting, rapid breathing,
refusing to feed, chest
indrawing, RR, nasal flaring,
temperature, heart rate,
crepitations, bronchial
breathing or reduced
air entry, rhonchi, grunting
Temperature .38.5C, refusing
to feed, and vomiting were
the most useful predictors of
severe pneumonia in infants,
whereas temperature .38.5C
and RR . 60/minute were the most
useful among children aged 1–4 years.
Mulholland et al [11] Philippines, Swaziland 730 Complete history,
physical examination
by pediatrician, and CXR
Cough, difficult breathing,
chest wall indrawing,
RR. Cases with wheeze
were excluded.
Sensitivity and specificity for RR .40/minute
or for lower chest wall indrawing
were between 0.77 and 0.81 in 2
different settings, but specificity
was lower when judged by a
healthcare worker.
Simoes and
McGrath [12]
Mbabane, Swaziland 362 Pediatrician’s assessment
on WHO criteria
Cough, difficult breathing,
ability to drink/feed well,
convulsions, abnormal
sleepiness, stridor,
severe undernutrition,
fever, wheeze, lower chest
wall indrawing, tachypnea, fever
Using RR and lower chest well
indrawing, nurses and nursing
assistants detected 71%–83% of
pneumonia cases with a specificity
of 84%–85%.
Abbreviations: CXR, chest radiograph; RR, respiratory rate; WHO, World Health Organization.
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WHO Radiologically Confirmed Pneumonia
It was obvious that each level of the hierarchy of the WHO
clinical case definition had a low specificity and negative pre-
dictive value: a raised respiratory rate is observed in children
with anxiety, anemia, sepsis, and reactive airway disease; lower
chest wall indrawing may be observed in any condition that
leads to tachypnea; and the danger signs incorporated in the
very severe pneumonia definition apply to the ‘‘final common
pathway’’ of a wide variety of pathogenic processes. In clinical
practice, the disadvantage of a low negative predictive value
was simply overtreatment. However, when it came to assessing
the impact on pneumonia of new conjugate vaccines against
Haemophilus influenzae type b (Hib) and pneumococcus, the
low specificity of the WHO clinical case definition would have
diluted the measured impact considerably. In response to this, the
WHO undertook a parallel review to produce a case definition
that was specific for pneumonia caused by these 2 principal bac-
teria. The definition selected was based on a common inter-
pretation of chest radiographs [19]. In a trial in The Gambia, the
measured efficacy of pneumococcal conjugate vaccine against
WHO radiologically confirmed pneumonia was 37%, arguing
that the specificity of the case definition was very high, par-
ticularly because the efficacy against all invasive pneumo-
coccal disease was only 50% [20]. Although high specificity is
desirable in any epidemiological inquiry, the WHO radio-
logical definition was deliberately biased to capture bacterial
pneumonia and would not serve well in an investigation of
pneumonia etiology in general.
Refining the WHO Clinical Case Definition for Perch
The WHO clinical case definition is highly sensitive but lacks
specificity. The WHO radiological definition is specific for Hib
and pneumococcus but lacks sensitivity for other etiologies.
Unfortunately, there are no clinicopathological data available
to develop a case definition that lies more practically between
these 2 extremes. Therefore, at the outset of the PERCH project,
we selected the sensitive WHO clinical case definition. This
would allow us to capture the full spectrum of pneumonia eti-
ologies. It would also allow us to project our etiologic distri-
bution to other studies (eg, CHERG) that have estimated the
burden of childhood pneumonia using the same definition. The
poor specificity of the definition means that some children
without an infectious etiology (eg, paraffin ingestion, congenital
heart disease) would be enrolled in the study and subsequently
found not to have pneumonia. However, using the WHO
clinical case definition would not only provide wide compara-
bility to other studies and wide clinical experience, it may allow
us to suggest refinements to improve its specificity.
The next step was to review the details of this definition
against the purpose of an etiology study. The PERCH case def-
inition was refined through an iterative process of presentation,
criticism, and response during in-person meetings and tele-
conferences, first with a globally representative group of pneu-
monia experts, the Pneumonia Methods Working Group
(PMWG) [21], and later with the investigators from the 7 sites.
The final resolution of the case definition is shown in Supple-
mentary Figure 2. The key areas of adaptation are summarized
below.
CLINICAL SIGNS IN YOUNG INFANTS
Although the basic structure of the WHO clinical case definition
has been fixed since 1990, there have been amendments and
refinements that are reflected by subsequent WHO documents.
For example, nasal flaring and grunting (in infants) are not
consistently identified as part of the WHO definition of severe
pneumonia [16, 17]. Within a multicenter study, we needed
a constant reference definition; in the interests of parsimony and
persuaded by the argument that children with these 2 signs
would almost certainly be included on the basis of lower chest
wall indrawing or yet more severe signs, we did not include them
in the PERCH case definition.
The WHO clinical case definition applies to children aged
2–59 months, but the PERCH study aims to investigate
children from 28 days of age. Children aged ,2 months with
pneumonia present with a broader spectrum of clinical symp-
toms and signs than older children [22, 23]. For the purposes
of PERCH, we extrapolated the WHO case definition, in-
cluding the requirement for cough or difficulty breathing, to
children aged 29–59 days. Lethargy is difficult to define and
assess in children in the second month of life so we adopted
the following definition for this age group: ‘‘an infant who
does not wake up on stimulation or, on waking, subsequently
moves only on stimulation or does not move at all’’ [24].
Convulsions
The WHO classification defines children who present with
cough or difficulty breathing and have convulsions as ‘‘very
severe pneumonia.’’ The PERCH site investigators argued that
this would incorporate a significant number of children who
presented with simple febrile seizures but had no underlying
pneumonia. A febrile illness can lead to both difficulty breathing
and a simple febrile convulsion. A febrile convulsion is a single
seizure in a 24-hour period lasting,15 minutes in a child with
a history of fever [25]. Within the WHO clinical case defini-
tion of very severe pneumonia, we refined the interpretation
of ‘‘convulsions’’ to encompass 2 precisely defined events:
(1) a single convulsion lasting for $15 minutes or (2) at least
2 convulsions within a 24-hour period during the current illness.
Wheeze
Lower chest wall indrawing may be caused by wheeze, which
is common among young children in some regions and is itself
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due to asthma, bronchiolitis, or occasionally bacterial pneumo-
nia. The PERCH project is focused on pneumonia, not bron-
chiolitis or asthma; therefore, to optimize the proportion of
children admitted to the study who have pneumonia as their
underlying pathology, we introduced a filter based on the
assessment strategy for wheeze recommended by WHO [17].
Children ,2 years of age with lower chest wall indrawing and
wheeze will be given at least 1 dose of a rapid-acting bron-
chodilator by inhaler, and children aged$2 years will be given
3 doses. Children whose lower chest wall indrawing resolves
with this therapy, regardless of its effect on wheeze, will be
excluded from the pool of severe pneumonia patients. In this
definition, ‘‘wheeze’’ refers to a characteristic whistling sound
on expiration that may be heard either on auscultation or
on general examination of the child. Children who meet the
criteria for very severe pneumonia will be included in PERCH,
regardless of the presence or absence of wheeze.
The filter for wheeze is likely to remove children with
reactive airways disease but will exclude only a minority of
patients with bronchiolitis. The clinical presentation of
bronchiolitis overlaps substantially with that of pneumonia
and, because children with bronchiolitis can develop a com-
plicating bacterial pneumonia, the treatment of bronchiolitis
is similar to that of pneumonia; therefore, it is reasonable to
include them within the scope of the project. They may be
separated at the analysis stage on the basis of clinical charac-
teristics (eg, wheeze, hyperinflation, and fine crackles on aus-
cultation) and young age.
HOSPITAL-ASSOCIATED PNEUMONIA
In developed countries, the concept of hospital-associated
pneumonia is well established. In developing countries, although
data are extremely sparse [26], there is no reason to suppose that
hospital-associated infections are any less common. The pattern of
pathogens causing hospital-associated pneumonia is characteris-
tically different from that causing community-acquired pneu-
monia, with greater representation of gram-negative bacteria
such as Klebsiella pneumoniae and Pseudomonas aeruginosa and
greater prevalence of multiple antibiotic resistance [27, 28].
The objective of the PERCH study is to provide etiologic
information to guide prevention and treatment of community-
acquired pneumonia, and we therefore modified the case defi-
nition to exclude children who have been admitted overnight to
any hospital within the last 14 days.
A related problem is the development of pneumonia among
children who have already been admitted to hospital. If this
occurs 48 hours after admission, it is normally considered
hospital-associated. However, some children who present at
the early stages of an episode of pneumonia do not manifest
all of the clinical signs necessary to diagnose the condition but
develop them over the next 24–48 hours. This is a relatively
infrequent occurrence and it would require considerably
more resources to ascertain than a study targeted on the ad-
mission assessment. Furthermore, the project seeks to guide
the admission management of community-acquired pneu-
monia, and these cases cannot contribute to that guidance.
Therefore, we did not include them in PERCH.
CHRONIC PNEUMONIA
Children with chronic respiratory symptoms are likely to have
a different spectrum of pathological processes. However, if their
disease is sufficiently severe to warrant admission and to meet
the definition of severe or very severe pneumonia, then acute
pneumonia may be a component of their illness. The un-
derlying etiology of this group may be different, and such
differences will be drawn out in the analysis on the basis of
length of history, but there are no exclusion criteria in PERCH
based on the duration of symptoms.
EVALUATING THE SEVERITY OF PNEUMONIA
In a multisite study of etiology, geography is a key variable of
interest. After accounting for variation in major risk factors,
such as human immunodeficiency virus infection or sickle cell
anemia, are there region-specific differences in etiological agents
that provide additional clues about the epidemiology of the
disease? One of the strongest confounders for this analysis is
disease severity on admission, which may vary as a function of
either hospital practice or health-seeking behavior. If one study
site recruits less severe cases of pneumonia and another recruits
only those in extremis, then the etiologic differences are likely
to be due to the admission policy rather than to geographic
location. To control for this, we aimed to define an index of
clinical severity. The WHO clinical case definition provides
only 2 grades—severe pneumonia and very severe pneumo-
nia—and although these are associated with clinical outcome
[29, 30], they provide a relatively coarse classification to control
for a potential confounder. We considered several approaches
to provide a finer grading.
The most efficient approach is to use an existing standard
such as the British Thoracic Society guidelines, which classify
children as having mild or severe pneumonia but also provide
criteria for admission to hospital and for transfer to the intensive
care unit [31]. Most of the features used to differentiate the
strata are shared with the WHO clinical case classification. A
finer differentiation would require considerably more clinical
and laboratory data, but the published literature does not provide
guidance on the optimal utility of such data.
A second approach is to focus on a single relevant parameter
of clinical physiology, the oxygen saturation of the blood. Pulse
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oximeters are readily available and widely used in developing
countries. Hypoxemia has been extensively studied and is as-
sociated with a 2- to 5-fold increase in mortality [32–35].
However, a pulse oximeter may underestimate arterial oxygen
saturation if it is incorrectly placed or if the patient has poor
peripheral perfusion. In addition, whereas mortality in many
cases of pneumonia is driven by poor oxygen exchange, it is not
the only mechanism that can lead to death. Oxygen saturation
will not accurately capture the degree of mortality risk among
pneumonia cases that are threatened by, for example, septic
shock, renal failure, or severe anemia.
The third approach we considered, and the one endorsed by
the PMWG, was to collect all of the relevant clinical data
available at each study site and use these data retrospectively to
define a severity index by comparison against a gold standard
such as fatal outcome. Such a modeling approach could also be
extended to explore whether individual clinical features, or
groups of features, are predictive of specific etiological causes,
after accounting for severity. The PERCH study protocol in-
cluded.50 clinical and laboratory variables, refined by PMWG
review, which will be obtained on admission from every
child. In addition, dynamic measures of severity, including
pyrexia, respiratory rate, oxygen saturation, and oxygen re-
quirement, will be obtained 24 hours and 48 hours after first
assessment.
STANDARDIZING THE CLINICAL ASSESSMENT
OF PNEUMONIA
A clinical case definition is of little value unless its component
clinical features are elicited and interpreted with consistency,
both between individuals and within individuals over time.
In children in developing countries, the assessment of res-
piratory signs shows marked variation between different pairs
of clinicians working in the same pediatric service [36], and
the ability of HCWs to elicit ‘‘soft’’ signs (eg, lethargy) con-
sistently is limited [12]. More pertinent, the j score for in-
terobserver variation among investigators in Tanzania for the
key sign of lower chest wall indrawing was ,0.4 [37].
Therefore, we considered it vital to adopt an active approach
to the standardization of clinical assessment in PERCH.
First, we recruited a senior clinician with long experience of
pediatrics in a developing country to design and lead the pro-
gram as a clinical standardization coordinator. She began with
a set of written and visual materials, focusing on the clinical
symptoms and signs in the PERCH clinical case definition and
on key severity markers (eg, measurement of oxygen saturation).
The interpretation of clinical signs was then debated, amended,
and finally endorsed by the site investigators. The coordinator
visited each site immediately before initiation of the study and
used a standard set of materials (with particular emphasis on
video and sound recordings) to train all staff involved in clinical
assessment or clinical specimen sampling. Lectures were sup-
plemented by clinical case scenarios and practical ward-based
sessions. Every participant was tested for competency at the end
of the training. Each site appointed 1 or more local clinical
standardization monitor(s), who participated actively in the
startup training and established a local program of monthly
refresher training. The original standardized teaching materials,
available to all staff on a clinical standardization Web site, ac-
cessed through the PERCH sharepoint, were used for both
refresher training and the training of new clinical staff. Every
3 months the coordinator posts an evaluation on the Web site,
comprising multiple choice questions and new video record-
ings of key clinical signs for interpretation, which permits
comparison of the performance of clinical staff at each site, as
well as cross-site comparisons. Results of evaluations are also
used to guide the content of subsequent refresher training and
to identify individuals or sites in need of increased support.
Through monitoring of case record forms, the relative fre-
quency with which clinicians at the same site diagnose severe
or very severe pneumonia is used to alert the coordinator to
possible discrepancies in the local clinical standardization
process. The initial standards will be reinforced by a second
training visit by the coordinator during the first year of the
study.
CONCLUSIONS
PERCH uses a constellation of clinical symptoms and signs to
define the syndrome of severe or very severe pneumonia in
hospitalized children aged 1–59 months. Any syndromic focus
inevitably simplifies the complex interaction of acute disease
and underlying risk factors that influence morbidity and
mortality in the developing world. Pneumonia occurs against
a background of nonpulmonary risk factors or chronic lung
disease; it varies in severity and duration; and the unique
nature of its clinical characteristics is shaped by the epide-
miology of other diseases (especially malaria) and by the
patterns of health-seeking behavior, which vary markedly by
region. We recognize that the PERCH case definition excludes
important parts of the spectrum of childhood pneumonia,
such as nonsevere pneumonia, nonhospitalized pneumonia,
pneumonia in older children and neonates, and hospital-
associated pneumonia. However, by anchoring the study in
a widely recognizable clinical case definition, formulated and
refined byWHO over 2 decades, and by focusing on an age group
(1–59 months) that bears the brunt of pneumonia mortality,
PERCH will yield comparable results from a wide spectrum of
epidemiological settings that can be linked to the broad ex-
isting literature on childhood pneumonia and to current
models of the global burden of childhood diseases.
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Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online
(http://www.oxfordjournals.org/our_journals/cid/). Supplementary materi-
als consist of data provided by the author that are published to benefit the
reader. The posted materials are not copyedited. The contents of all sup-
plementary data are the sole responsibility of the authors. Questions or
messages regarding errors should be addressed to the author.
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